AZTR Azitra Inc Gross Profit Rate

Azitra, Inc. (AZTR) is implementing advanced biotherapeutic methods to combat severe skin pathologies, ensuring sustainable demand. The gross margin percentage on the GURU.Markets platform chart reflects the market reaction, where 0.00 shows the current volume of the metric. Revenues are based on insurance payouts for gene-modified drugs, while robotic bioreactor systems minimize contamination risks during the production of recombinant proteins.
Analytical breakdowns and data insights for company Azitra (AZTR)

For the microbiome-based biotech company Azitra, Inc. (AZTR), this metric reflects the efficiency of cost management in developing treatments for eczema and ichthyosis. The aggregate gross margin is calculated as the portion of revenue minus direct production costs, demonstrating the business's ability to generate profit from each unit of product. Analyzing the aggregate gross margin trend allows for an assessment of the company's long-term sustainability and helps avoid purchasing the asset at the peak of its overvaluation.